Uwe Rix
University of South Florida(US)Moffitt Cancer Center(US)
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Peptidase Inhibition and Analysis, Lung Cancer Treatments and Mutations, Protein Degradation and Inhibitors, Phagocytosis and Immune Regulation
Most-Cited Works
- → Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets(2007)656 cited
- → Target profiling of small molecules by chemical proteomics(2008)563 cited
- → A chemical and phosphoproteomic characterization of dasatinib action in lung cancer(2010)282 cited
- → The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib(2007)279 cited
- → Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells(2008)275 cited
- → Modification of post-PKS tailoring steps through combinatorial biosynthesis(2002)261 cited
- → Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib